ASXC
Asensus Surgical Inc.
+133.4%
Realized return across 16 closed trades.
Last close 8 Jan 2024
Welcome. I'm Dirk Kuyken, and this is where I share how I think about investing, the portfolio I'm building, and the lessons that shape the journey.
Average yearly CAGR
+48.8%Win ratio
87.98%Certification
Syntra PXLYTD summary
YTD P/L
Monthly results
YTD trades
+100.0% win ratio on closed trades.
Latest posts
Familiar faces, new perspectives…
One of the things I enjoyed most at the eToro Popular Investor Summit was catching up with familiar faces and meeting new people. I enjoyed hearing how other investors approach investing and what they expect from the markets. In those conversations, I heard about the difficulties other Popular Investors have faced this year. I appreciated hearing how others are handling it. Not only the negative returns, but also the impact on their copier base. Behind those numbers are people investing alongside us. We share the difficult periods with our copiers too, and it was good to talk openly about that. The Copy Tank and the 2027 market forecast were highlights too. The AI presentations had a more immediate impact. I’ve already changed how I use Grok Bot, and they’ve given me plenty to think about in my work as a software engineer as well. Thank you to the eToro team and everyone I had the chance to speak with. It was good to spend time together! Have a nice Sunday! Copy Trading is not investment advice | Capital at risk | Past performance does not guarantee future results.
8 Nov 2026
NuScale Q3: cash buys time, not a customer…
Two weeks ago I wrote that my confidence in $SMR had weakened. Q3 doesn’t change that. 🟢 What’s going well: Doosan has started building parts for the first commercial reactor module. Real progress, not just plans. NuScale still has about $1.9B in cash and investments and no debt. The loss was $0.11 a share, versus -$1.85 a year ago when there was a big one-off charge. Costs stayed around $65M this quarter, and management says that should stay fairly steady until a real project starts. 🔴 What’s not: Revenue was only $281K, down from $8.2M a year ago, after the old Romania engineering work ended. Over nine months the company used about $401M of cash running the business (up from $256M a year earlier). Part of that was catching up on bills, but they’re still burning cash. Talks with TVA have been going for about 14 months and there’s still no signed power deal. Even that deal wouldn’t mean NuScale starts selling reactors until there’s also a separate manufacturing contract. That $1.9B gives them years to keep working. But most of it came from issuing new shares: roughly 90 million in nine months, about 29% more shares than before. So the cash pile buys time, and it also shows how costly that time has been for existing shareholders. If a real customer deal stays late, more dilution stays a risk. For me it’s the same as late October: the tech can still work, but the stock turns on a binding customer, not on one quiet quarter. Patience only works if we’re honest about the cash clock and the dilution... Have a good morning! Copy Trading is not investment advice | Capital at risk | Past performance does not guarantee future results.
6 Nov 2026
Aeva Q3: a record quarter, but still early days... 🔍
$AEVA reported its Q3 numbers after the close, and it was a good one for our lidar names. 🟢 What I liked: - Revenue $6.7M, a company record and about +86% compared to last year, above expectations - Adjusted loss of $0.39 per share, better than the -$0.43 analysts expected - First revenue from optical connectivity, with chipsets for AI data centers, and a second customer in talks - The US Air Force and Navy picked Aeva for airborne autonomy work, and Micro-Epsilon signed a multi-year supply deal that starts with several thousand sensors - Shipments to Daimler Truck are growing 🔴 What I keep an eye on: - Almost half of revenue ($3.2M) is still professional services, not products - The GAAP operating loss grew to $39.1M, from $33.2M a year ago - Cash burn was $87.4M over the first nine months. Liquidity is $272.5M including a $125M facility, so there is runway, but it's not unlimited... - No formal guidance For me this is a step in the right direction. Data centers and defense next to automotive give Aeva more ways to win, but I want to see product revenue take over from engineering fees. Patience is key... Do you think Aeva can turn these deals into real product revenue in 2027? 👇 Have a nice evening! Copy Trading is not investment advice | Capital at risk | Past performance does not guarantee future results.
5 Nov 2026
About me
Based in Belgium and working in technology, I approach investing the same way I approach systems: understand the moving parts, strip away noise, and stay accountable to the process.
My portfolio was shaped by property investing, my move to Brazil, early mistakes, and a gradual shift toward a more grounded long-term investment framework.
Read the full storyStrategy
The strategy balances conviction with structure: swing trades for defined setups, growth exposure for developing companies and sectors, and ETFs for long-term compounding stability.
Recommended holding period
+6 months
Return target
Aspirational CAGR of +25%
Last 3Y realized CAGR +48.8%
Risk posture
High volatility accepted, discipline required
Past winners
Closed-trade winners from 4 Mar 2020 to 4 Aug 2026.
ASXC
Asensus Surgical Inc.
+133.4%
Realized return across 16 closed trades.
Last close 8 Jan 2024
QBTS
D-Wave Quantum Inc
+45.1%
Realized return across 11 closed trades.
Last close 8 May 2025
TRX
TRON
+73.6%
Realized return across 71 closed trades.
Last close 22 Oct 2025
ADA
Cardano
+58.1%
Realized return across 59 closed trades.
Last close 4 Mar 2025